Özakbaş, S. Et Al. 2022. Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies. MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.58 .

Özakbaş, S., Baba, C., Doğan, Y., Cevik, S., Özçelik, S., & Kaya, E., (2022). Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies. MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.58.

Özakbaş, SERKAN Et Al. "Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies," MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.58, 2022

Özakbaş, SERKAN Et Al. "Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies." MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.58, 2022

Özakbaş, S. Et Al. (2022) . "Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies." MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.58.

@article{article, author={SERKAN ÖZAKBAŞ Et Al. }, title={Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies}, journal={MULTIPLE SCLEROSIS AND RELATED DISORDERS}, year=2022}